On this date in 1910, students at the University of North Dakota were studying for their final exams. Registration Day on that year's calendar was February 8, so they were also considering classes to take during the upcoming spring semester.
Topline data from a novel Phase III study show that the biologic TREMFYA ® facilitated rapid and significant clearance in moderate to severe scalp psoriasis and significant improvement in scalp.
First-of-a-kind psoriasis study outcomes revealed europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson announced today that Tremfya achieved rapid and significant healing of moderate-to-severe scalp psoriasis , and improved scalp itching and health-related quality of life outcomes.